C71P1ZZ
Planar Nuclear Medicine Imaging Lymphatics, Lower Extremity to None with None, Technetium 99m (Tc-99m) Approach
Procedural Specifications
| Clinical Axis | Detail Definition |
|---|---|
| Section | C Nuclear Medicine |
| Body System | 7 Lymphatic and Hematologic System |
| Operation | 1 Planar Nuclear Medicine Imaging |
| Body Part | P Lymphatics, Lower Extremity |
| Approach | 1 Technetium 99m (Tc-99m) |
| Device | Z None |
| Qualifier | Z None |
Operation Definition
Introduction of radioactive materials into the body for single plane display of images developed from the capture of radioactive emissions
Procedure Overview
Planar nuclear medicine imaging of the lymphatic and hematologic system covers single-plane scans that track how a radioactive tracer moves through lymph channels and nodes, or how it distributes through components of the blood. The best-known example is lymphoscintigraphy, in which a small dose of tracer is injected near a tumor site or in tissue and a gamma camera follows its path as it drains into nearby lymph nodes.
This type of imaging is used heavily in cancer surgery planning, particularly for breast cancer and melanoma, to identify the sentinel lymph node - the first node a tumor would drain to - so a surgeon can remove and biopsy that specific node rather than a wider group of nodes. It is also used to evaluate lymphedema, a condition where fluid builds up because lymph vessels are blocked or not draining properly, by showing where the flow of tracer slows or stops.
Anatomy & Axis Detail
Lymphatics, Lower Extremity
The lower extremity lymphatic network drains the leg, thigh, and groin toward the inguinal and iliac nodal chains, and planar imaging of this region is most often performed as lymphoscintigraphy to evaluate suspected lymphedema or to trace lymphatic flow after trauma, filariasis, or prior lymph node dissection. A radiotracer, typically a technetium-99m sulfur colloid, is injected in the web spaces of the toes or dorsum of the foot, and sequential two-dimensional images are acquired as the tracer migrates proximally. Delayed and dermal backflow patterns, dermal diffuse uptake, and asymmetric transit times between limbs are the key findings recorded. Because lymphatic flow in an obstructed or hypoplastic limb can be sluggish, imaging sessions frequently extend over several hours, with the body part designation limited strictly to the leg being studied rather than the contralateral limb or trunk.
Radionuclide: Technetium 99m (Tc-99m)
Technetium 99m (Tc-99m) is the most widely used radionuclide in Nuclear Medicine, valued for its short half-life and favorable gamma energy for imaging bone, cardiac, renal, and other organ systems. In this axis position it records that a technetium-based radiopharmaceutical was the tracer administered for the study, distinguishing it from the many other specific isotopes, such as thallium or iodine compounds, used for more specialized indications.
Coding & Documentation
The clinical note should specify the injection site, the substance traced, and confirm that the images acquired were flat, single-plane pictures. Sentinel node mapping studies are frequently paired with a same-day surgical excision, and coders need to capture the imaging and the surgical removal as separate procedures even though they are clinically linked. A common mistake is failing to distinguish a lymphatic mapping study from a general blood-pool or marrow imaging study, since both fall under the same body system in the classification but represent very different clinical targets.
Commonly Confused With
This family is frequently confused with Tomographic Nuclear Medicine Imaging of the same body system, which produces three-dimensional images rather than flat ones and is often used for spleen or bone marrow studies rather than lymph node mapping; the report's description of the acquisition technique settles which applies. It is also sometimes confused with sentinel node biopsy itself, which is a separate excision procedure coded outside of Nuclear Medicine even when performed immediately after the imaging study that located the node.